Revenue
$1.94BFY 2025EDGAR Company Profile
莫德纳（MRNA）Moderna,
价值投资看板
Based on FY 2025 10-KGross Margin
—Gross Profit / RevenueNet Margin
-145.2%Net Income / RevenueROE
-32.6%Net Income / EquityDebt / Assets
29.9%Liabilities / AssetsRevenue CAGR (5Y)
-43.0%From latest 5 fiscal yearsRevenue YoY
-39.9%2025 vs 2024EPS Diluted
-7.26FY 2025公司基本信息
可由 EDGAR 与主数据维护- Legal Name
- Moderna, Inc.
- Ticker
- MRNA
- Requested Id
- CIK0001682852
- CIK
- 1682852
- Sector
- —
- Industry
- —
- Exchange
- —
- Latest 10-K Year
- 2025
- Latest 13F Holdings Date
- 2025-03-31
研究焦点
供价值投资用户快速判断- 盈利质量: 毛利率/净利率是否稳定，是否随周期大幅波动。
- 资本效率: ROE 是否长期高于资本成本。
- 财务安全边际: 负债占资产比例与现金流覆盖能力。
- 增长质量: 5年营收 CAGR 与当年同比是否一致。
- 机构共识: 前十大持仓机构集中度与持续持有情况。
年报关键指标（10-K）
最近 6 年| Line Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.94B | $3.24B | $6.85B | $19.26B | $18.47B | $803.0M |
| Gross Profit | — | — | — | — | — | — |
| Operating Income | $-3.07B | $-3.94B | $-4.24B | $9.42B | $13.30B | $-763.0M |
| Net Income | $-2.82B | $-3.56B | $-4.71B | $8.36B | $12.20B | $-747.0M |
| Operating Cash Flow | $-1.87B | $-3.00B | $-3.12B | $4.98B | $13.62B | $2.03B |
| Total Assets | $12.34B | $14.14B | $18.43B | $25.86B | $24.67B | $7.34B |
| Total Liabilities | $3.69B | $3.24B | $4.57B | $6.74B | $10.52B | $4.78B |
| Shareholders' Equity | $8.65B | $10.90B | $13.85B | $19.12B | $14.14B | $2.56B |
| EPS Basic | -7.26 | -9.28 | -12.33 | 21.26 | 30.31 | -1.96 |
| EPS Diluted | -7.26 | -9.28 | -12.33 | 20.12 | 28.29 | -1.96 |
投资人最近持仓（13F）
as of 2025-03-31HolderWeightValueReport